Literature DB >> 20159588

A PAK-activated linker for EGFR and FAK.

Alok Tomar1, David D Schlaepfer.   

Abstract

Transmembrane growth factor and integrin matrix receptors form multiprotein signaling complexes with FAK, a cytoplasmic cell motility-associated kinase. In a recent issue of Molecular Cell, Long et al. now show that a PAK-phosphorylated alternate-spliced isoform of the steroid receptor coactivator-3 (SRC-3Delta4) bridges EGFR and FAK, enhancing breast carcinoma cell migration and metastasis. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159588      PMCID: PMC3081666          DOI: 10.1016/j.devcel.2010.01.013

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  10 in total

Review 1.  Biology of the p21-activated kinases.

Authors:  Gary M Bokoch
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

2.  Steroid receptor coactivator-3, a homolog of Taiman that controls cell migration in the Drosophila ovary, regulates migration of human ovarian cancer cells.

Authors:  Hiroyuki Yoshida; Jinsong Liu; Shaija Samuel; Wenjun Cheng; Daniel Rosen; Honami Naora
Journal:  Mol Cell Endocrinol       Date:  2005-11-18       Impact factor: 4.102

Review 3.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

4.  Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.

Authors:  Shu-Yi Chen; Hong-Chen Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 5.  Focal adhesion kinase: in command and control of cell motility.

Authors:  Satyajit K Mitra; Daniel A Hanson; David D Schlaepfer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

6.  SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration.

Authors:  Weiwen Long; Ping Yi; Larbi Amazit; Heather L LaMarca; Felicity Ashcroft; Rakesh Kumar; Michael A Mancini; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell       Date:  2010-02-12       Impact factor: 17.970

7.  Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression.

Authors:  Jun Yan; Halime Erdem; Rile Li; Yi Cai; Gustavo Ayala; Michael Ittmann; Li-yuan Yu-Lee; Sophia Y Tsai; Ming-Jer Tsai
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells.

Authors:  Alok Tomar; Ssang-Taek Lim; Yangmi Lim; David D Schlaepfer
Journal:  J Cell Sci       Date:  2009-05-12       Impact factor: 5.285

9.  Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.

Authors:  Ronald Reiter; Annabell S Oh; Anton Wellstein; Anna Tate Riegel
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

Review 10.  The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.

Authors:  Tyler Lahusen; Ralf T Henke; Benjamin L Kagan; Anton Wellstein; Anna T Riegel
Journal:  Breast Cancer Res Treat       Date:  2009-05-06       Impact factor: 4.872

  10 in total
  11 in total

1.  Governing epidermal homeostasis by coupling cell-cell adhesion to integrin and growth factor signaling, proliferation, and apoptosis.

Authors:  Geulah Livshits; Agnieszka Kobielak; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

2.  ZINC4085554 inhibits cancer cell adhesion by interfering with the interaction of Akt1 and FAK.

Authors:  Shyam K More; Emilie E Vomhof-Dekrey; Marc D Basson
Journal:  Oncol Lett       Date:  2019-03-27       Impact factor: 2.967

3.  Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer.

Authors:  Hong-Fei Ji; Da Pang; Song-Bin Fu; Yan Jin; Lei Yao; Ji-Ping Qi; Jing Bai
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-11       Impact factor: 4.553

4.  VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.

Authors:  Chunhai Huang; Xianrui Yuan; Yi Wan; Fei Liu; Xiaoyu Chen; Xianquan Zhan; Xuejun Li
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

5.  High RAC3 expression levels are required for induction and maintaining of cancer cell stemness.

Authors:  Laura C Panelo; Mileni Soares Machado; María F Rubio; Felipe Jaworski; Cecilia V Alvarado; Leonardo A Paz; Alejandro J Urtreger; Elba Vazquez; Mónica A Costas
Journal:  Oncotarget       Date:  2017-12-22

6.  The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer.

Authors:  Wenli Liu; Lisha Sun; Juan Zhang; Wengang Song; Mingcheng Li; Hong Wang
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

7.  Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901.

Authors:  Li Dan; Ding Jian; Lin Na; Wang Xiaozhong
Journal:  Onco Targets Ther       Date:  2012-10-23       Impact factor: 4.147

8.  β3 integrin-mediated spreading induced by matrix-bound BMP-2 controls Smad signaling in a stiffness-independent manner.

Authors:  Laure Fourel; Anne Valat; Eva Faurobert; Raphael Guillot; Ingrid Bourrin-Reynard; Kefeng Ren; Laurence Lafanechère; Emmanuelle Planus; Catherine Picart; Corinne Albiges-Rizo
Journal:  J Cell Biol       Date:  2016-03-07       Impact factor: 10.539

9.  Pak1 Kinase Maintains Apical Membrane Identity in Epithelia.

Authors:  Mario Aguilar-Aragon; Ahmed Elbediwy; Valentina Foglizzo; Georgina C Fletcher; Vivian S W Li; Barry J Thompson
Journal:  Cell Rep       Date:  2018-02-13       Impact factor: 9.423

Review 10.  Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.

Authors:  Rayan Naser; Abdullah Aldehaiman; Escarlet Díaz-Galicia; Stefan T Arold
Journal:  Cancers (Basel)       Date:  2018-06-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.